InsidersTradesSigma
Discover the detailed record of transactions filed by Worthington Mark, Conseiller Juridique Général. Officer active across 1 company, notably Athira Pharma, Inc.. In total, 1 disclosures have been recorded. Activity tracked since 18 May 2022. The latest transaction was disclosed on 18 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Mark Worthington serves as the General Counsel at Athira Pharma, Inc. In this role, he is responsible for managing the company's legal affairs. Athira Pharma, Inc. is a biopharmaceutical company focused on developing innovative treatments. Mark leverages his expertise to ensure legal compliance and support the company's strategic objectives.